Variables . | Univariate . | Multivariate . | 95% CI . | P-value . |
---|---|---|---|---|
P-value . | Odds ratio . | |||
Risk factors for long-term survival | ||||
Age (years) | 0.002 | 1.2 | 1.0–1.4 | 0.03 |
NYHA class | 0.02 | 2.4 | 0.6–8.3 | 0.2 |
Male sex | 0.4 | |||
Mitral stenosis | 0.4 | |||
Atrial fibrillation | 0.7 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.2 | |||
LVEF (%) | 0.09 | 0.9 | 0.9–1.0 | 0.03 |
TAD index (mm/m2) | 0.1 | 1.0 | 0.8–1.3 | 0.9 |
Risk factors for heart failure | ||||
Age (years) | 0.1 | 1.1 | 0.9–1.3 | 0.3 |
NYHA class | 0.07 | 3.5 | 0.6–19.4 | 0.2 |
Male sex | 0.6 | |||
Atrial fibrillation | 0.5 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.6 | |||
LVEF (%) | 0.03 | 0.9 | 0.8–0.9 | 0.04 |
Variables . | Univariate . | Multivariate . | 95% CI . | P-value . |
---|---|---|---|---|
P-value . | Odds ratio . | |||
Risk factors for long-term survival | ||||
Age (years) | 0.002 | 1.2 | 1.0–1.4 | 0.03 |
NYHA class | 0.02 | 2.4 | 0.6–8.3 | 0.2 |
Male sex | 0.4 | |||
Mitral stenosis | 0.4 | |||
Atrial fibrillation | 0.7 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.2 | |||
LVEF (%) | 0.09 | 0.9 | 0.9–1.0 | 0.03 |
TAD index (mm/m2) | 0.1 | 1.0 | 0.8–1.3 | 0.9 |
Risk factors for heart failure | ||||
Age (years) | 0.1 | 1.1 | 0.9–1.3 | 0.3 |
NYHA class | 0.07 | 3.5 | 0.6–19.4 | 0.2 |
Male sex | 0.6 | |||
Atrial fibrillation | 0.5 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.6 | |||
LVEF (%) | 0.03 | 0.9 | 0.8–0.9 | 0.04 |
CI: confidence interval; TR: tricuspid regurgitation; NYHA: New York Heart Association; LVEDD: left ventricular end-diastolic diameter; LAD: left atrial diameter; LVEF: left ventricular ejection fraction; TAD: tricuspid annulus diameter; TAD index: TAD/body surface area.
Variables . | Univariate . | Multivariate . | 95% CI . | P-value . |
---|---|---|---|---|
P-value . | Odds ratio . | |||
Risk factors for long-term survival | ||||
Age (years) | 0.002 | 1.2 | 1.0–1.4 | 0.03 |
NYHA class | 0.02 | 2.4 | 0.6–8.3 | 0.2 |
Male sex | 0.4 | |||
Mitral stenosis | 0.4 | |||
Atrial fibrillation | 0.7 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.2 | |||
LVEF (%) | 0.09 | 0.9 | 0.9–1.0 | 0.03 |
TAD index (mm/m2) | 0.1 | 1.0 | 0.8–1.3 | 0.9 |
Risk factors for heart failure | ||||
Age (years) | 0.1 | 1.1 | 0.9–1.3 | 0.3 |
NYHA class | 0.07 | 3.5 | 0.6–19.4 | 0.2 |
Male sex | 0.6 | |||
Atrial fibrillation | 0.5 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.6 | |||
LVEF (%) | 0.03 | 0.9 | 0.8–0.9 | 0.04 |
Variables . | Univariate . | Multivariate . | 95% CI . | P-value . |
---|---|---|---|---|
P-value . | Odds ratio . | |||
Risk factors for long-term survival | ||||
Age (years) | 0.002 | 1.2 | 1.0–1.4 | 0.03 |
NYHA class | 0.02 | 2.4 | 0.6–8.3 | 0.2 |
Male sex | 0.4 | |||
Mitral stenosis | 0.4 | |||
Atrial fibrillation | 0.7 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.2 | |||
LVEF (%) | 0.09 | 0.9 | 0.9–1.0 | 0.03 |
TAD index (mm/m2) | 0.1 | 1.0 | 0.8–1.3 | 0.9 |
Risk factors for heart failure | ||||
Age (years) | 0.1 | 1.1 | 0.9–1.3 | 0.3 |
NYHA class | 0.07 | 3.5 | 0.6–19.4 | 0.2 |
Male sex | 0.6 | |||
Atrial fibrillation | 0.5 | |||
Disease duration (m) | 0.6 | |||
LVEDD (ml) | 0.4 | |||
LAD (mm) | 0.6 | |||
LVEF (%) | 0.03 | 0.9 | 0.8–0.9 | 0.04 |
CI: confidence interval; TR: tricuspid regurgitation; NYHA: New York Heart Association; LVEDD: left ventricular end-diastolic diameter; LAD: left atrial diameter; LVEF: left ventricular ejection fraction; TAD: tricuspid annulus diameter; TAD index: TAD/body surface area.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.